Article Sidebar

PDF
Date Published: 21/06/2022
Abstract Views: 1106
Views PDF: 496
DOI: https://doi.org/10.51298/vmj.v514i2.2612
Issue
Vol. 514 No. 2 (2022)
Section
Các bài báo
How to Cite
Việt Hùng, Đinh . (2022). STUDY THERAPEUTIC EFFICACY IN GENERALIZED ANXIETY DISORDER. Vietnam Medical Journal, 514(2). https://doi.org/10.51298/vmj.v514i2.2612

STUDY THERAPEUTIC EFFICACY IN GENERALIZED ANXIETY DISORDER

Đinh Việt Hùng1,
1 Military Hospital 103

Main Article Content

Abstract

Objective: To evaluate treatment outcomes in generalized anxiety disorder. Object and method: 62 patients with generalized anxiety disorder who received inpatient treatment in the Psychiatric Department, 103 Military Medical Hospital. Results: Benzodiazepin was used 100% with average dose 8.27±2.18 mg/day. Treatment effectiveness was enhanced with a combination of psychotherapy: 24.19% of patients used relaxation therapy. Average day treatment was 13.72±2.61 days with 27.4% of patients discharged from hospital had mild anxiety and 3.22% of patients discharged from hospital had mild depression. Conclusion: The results of this study provide evidence for the therapeutic efficacy of pharmacotherapy in combination with psychotherapy in patients with generalized anxiety disorder.

Article Details

Keywords

Generalized anxiety disorder

References

1. Craske M.G., Stein M.B., Eley T.C. et al. (2017), “Anxiety disorders”, Nat Rev Dis Primers; 3: 17024.
2. Trần Nguyễn Ngọc (2018), “Đánh giá hiệu quả điều trị rối loạn lo âu lan tỏa bằng liệu pháp thư giãn-luyện tập”, Luận án tiến sỹ; Đại học y Hà Nội.
3. Gordon B.R., McDowell C.P., Lyons M. et al. (2017), “The effects of resistance exercise training on anxiety: A meta-analysis and meta-regression analysis of randomized controlled trials”, Sports Med; 47(12): 2521-2532.
4. Bandelow B. (2020), “Current and Novel Psychopharmacological Drugs for Anxiety Disorders”, Adv Exp Med Biol; 1191: 347-365.
5. Hershenberg R., Gros D.F. and Brawman-Mintzer O. (2014), “Role of atypical antipsychotics in the treatment of generalized anxiety disorder”, CNS Drugs; 28(6): 519-533.
6. Ströhle A., Gensichen J. and Domschke K. (2018), “The Diagnosis and Treatment of Anxiety Disorders”, Dtsch Arztebl Int; 155(37): 611-620.
7. Newman M.G. (2000), “Recommendations for a cost-offset model of psychotherapy allocation using generalized anxiety disorder as an example” J Consult Clin Psychol; 68(4): 549-555.
8. Dahl A.A., Ravindran A., Allgulander C., et al. (2005), “Sertraline in generalized anxiety disorder: efficacy in treating the psychic and somatic anxiety factors”, Acta Psychiatr Scand; 111(6): 429-435.